- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07652099
Cost-utility Analysis of the Use of a Laser Fiber in the Management of Non-abscessed Pilonidal Cyst (ACONIDAL)
11. juni 2026 opdateret af: Elsan
This multicenter, prospective, randomized, open-label trial compares laser fiber treatment with conventional surgery in adults with non-abscessed pilonidal cyst.
The main objective is to evaluate the incremental cost-utility ratio of laser fiber versus conventional surgery over 12 months from a societal perspective.
Secondary objectives include 3-month cost-utility, healing time, closure at 3 months, recurrence at 12 months, postoperative complications, treatment parameters, postoperative pain, and duration of sick leave.
Studieoversigt
Status
Ikke rekrutterer endnu
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Pilonidal cyst surgery is common in France and mainly affects young adults.
Conventional surgery is effective but may be associated with longer healing time, prolonged dressing use, and work absence.
Laser fiber treatment is a minimally invasive alternative used in France since 2019 and may reduce healing time and postoperative burden; however, prospective randomized comparative medico-economic evidence is lacking.
This national multicenter study randomizes adults with non-abscessed pilonidal cyst to laser fiber treatment or conventional surgery in a 1:1 ratio.
The primary endpoint is the incremental cost-utility ratio over 12 months, using total costs and utility derived from EQ-5D-5L (QALY).
Participants are followed from baseline to month 12, with assessments at J8, J15, M3, M6, M9, and M12.
Undersøgelsestype
Interventionel
Tilmelding (Anslået)
150
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiekontakt
- Navn: Charlène Py, Eng
- Telefonnummer: +33556003048
- E-mail: charlene.py@elsan.care
Studiesteder
-
-
-
Agen, Frankrig, 47000
- Clinique Esquirol Saint Hilaire ELSAN
-
Kontakt:
- Lucie RANDAZZO
- Telefonnummer: +335 53 69 12 53
- E-mail: lucie.randazzo@elsan.care
-
Ledende efterforsker:
- Damien LOUIS, MD
-
Caen, Frankrig, 14000
- Polyclinique du Parc - ELSAN
-
Kontakt:
- Elise DELARUE
- Telefonnummer: +332-30-32-28-49
- E-mail: elise.delarue@elsan.care
-
Ledende efterforsker:
- Julie LEQUET, MD
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Ingen
Beskrivelse
Inclusion Criteria:
- Male or female aged 18 years or older and younger than 80 years.
- Patient for whom excision of a non-abscessed pilonidal cyst by laser fiber or conventional surgery is indicated.
- Patient informed and having provided free, informed, written consent before any study-specific procedure.
Exclusion Criteria:
- Acute abscess.
- Contraindication to surgery and/or anesthesia.
- Need for urgent intervention for non-abscessed pilonidal cyst.
- Participation in another ongoing study or exclusion period.
- No health insurance coverage/protection.
- Legal protection measure or deprived of liberty by judicial or administrative decision.
- Hospitalized without consent.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Laser fiber
Laser fiber introduced through the cyst tract to destroy the cyst walls by thermal effect/burning; performed under general anesthesia with a small dry dressing afterwards.
|
Use of a laser fiber introduced through the pilonidal cyst tract to destroy the cyst walls.
Main steps include tract exploration, curettage, irrigation, two laser passes, and dry dressing.
|
|
Aktiv komparator: Conventional surgery
Complete excision of the cystic area by incision around the entire contour of the cyst, followed by placement of packing and an absorbent dressing; performed under general anesthesia.
|
Conventional surgical excision of the entire cystic area with packing and absorbent dressing.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Incremental cost-utility ratio (ICUR) of laser fiber versus conventional surgery
Tidsramme: 12 months after intervention
|
Calculated from total 12-month costs (direct medical, direct non-medical, indirect costs, including recurrences) and utility gain derived from EQ-5D-5L / QALY.
|
12 months after intervention
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Incremental cost-utility ratio at 3 months
Tidsramme: 3 months after intervention
|
3 months after intervention
|
|
|
Healing duration
Tidsramme: Up to 12 months after intervention
|
Up to 12 months after intervention
|
|
|
Closure of non-abscessed pilonidal cyst
Tidsramme: 3 months after intervention
|
3 months after intervention
|
|
|
Recurrence of non-abscessed pilonidal cyst
Tidsramme: 12 months after intervention
|
12 months after intervention
|
|
|
Postoperative complications
Tidsramme: Short term: intervention to day 15; medium term: day 15 to month 3; long term: month 6 to month 12
|
Short term: intervention to day 15; medium term: day 15 to month 3; long term: month 6 to month 12
|
|
|
Treatment parameters
Tidsramme: At day 0 intervention
|
Duration of intervention and occupation time of operating room.
|
At day 0 intervention
|
|
Postoperative pain evolution
Tidsramme: Baseline to 12 months after intervention Pain measured at J0, J8, J15, M3, M6, M9, M12.
|
Numeric Rating Scale with analgesic use taken into account.
|
Baseline to 12 months after intervention Pain measured at J0, J8, J15, M3, M6, M9, M12.
|
|
Duration of sick leave
Tidsramme: Up to 12 months after intervention
|
Days from hospital discharge after treatment to return to work.
|
Up to 12 months after intervention
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Anslået)
15. juni 2026
Primær færdiggørelse (Anslået)
15. december 2029
Studieafslutning (Anslået)
15. december 2029
Datoer for studieregistrering
Først indsendt
11. juni 2026
Først indsendt, der opfyldte QC-kriterier
11. juni 2026
Først opslået (Faktiske)
16. juni 2026
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
16. juni 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
11. juni 2026
Sidst verificeret
1. juni 2026
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- ACONIDAL
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Laser fiber treatment
-
Almirall, S.A.Afsluttet
-
Almirall, S.A.Afsluttet
-
University of EdinburghNHS LothianAfsluttetFibrose | LungekræftDet Forenede Kongerige
-
Almirall, S.A.Afsluttet
-
Instituto Grifols, S.A.Trukket tilbageHypofibrinogenemi | Medfødt afibrinogenæmiIndien, Kalkun, Libanon, Forenede Stater, Bulgarien
-
University of Wisconsin, MadisonNational Center for Advancing Translational Sciences (NCATS)AfsluttetAtrieflimrenForenede Stater
-
Grifols Therapeutics LLCInstituto Grifols, S.A.AfsluttetMedfødt afibrinogenæmiIndien, Forenede Stater, Italien, Libanon
-
Oregon Health and Science UniversityUniversity of Oregon; Oregon State UniversityRekrutteringKulhydratintoleranceForenede Stater
-
Stanford UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)RekrutteringAutismespektrumforstyrrelse | AutismeForenede Stater
-
University of California, San DiegoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) og andre samarbejdspartnereAfsluttet